{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:04:24Z","timestamp":1774425864328,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bioorg.2023.106593","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:20:12Z","timestamp":1683480012000},"page":"106593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents"],"prefix":"10.1016","volume":"137","author":[{"given":"Shabina B.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Meena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhajan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchir","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damodara N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106593_b0005","unstructured":"WHO, WHO fact sheet on Leishmaniasis, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis, 8 January 2022 (accessed on 30-03-2022)."},{"key":"10.1016\/j.bioorg.2023.106593_b0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00018-013-1491-1","article-title":"Mechanisms of cellular invasion by intracellular parasites","volume":"71","author":"Walker","year":"2014","journal-title":"Cell Mol. Life. Sci."},{"key":"10.1016\/j.bioorg.2023.106593_b0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2023.106593_b0020","unstructured":"WHO. Research Priorities for Chagas Disease, Human AfricanTrypanosomiasis and Leishmaniasis. World Health Organ. Technol. Rep. Ser. 975 (2012) 1\u2212100. https:\/\/apps.who.int\/iris\/handle\/10665\/77472."},{"key":"10.1016\/j.bioorg.2023.106593_b0025","first-page":"69","article-title":"Review of the current treatments for leishmaniases","volume":"3","author":"Lauletta","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.bioorg.2023.106593_b0030","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2023.106593_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112914","article-title":"Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal","volume":"209","author":"Thompson","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112668","article-title":"Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties","volume":"206","author":"Fersing","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/D0MD00083C","article-title":"Antileishmanial assessment of isoxazole derivatives against L. donovani","volume":"11","author":"Mukhopadhyay","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0050","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acs.jmedchem.5b01456","article-title":"Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity","volume":"58","author":"Mowbray","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0055","doi-asserted-by":"crossref","unstructured":"G. A. Gon\u00e7alves, A. R. Spillere, G. M. das Neves, L.P. Kagami, G. L. von Poser, R.F.S. Canto, V. Eifler-Lima, Natural and synthetic coumarins as antileishmanial agents: A review. Eur. J. Med. Chem. 203 (2020) 112514. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112514.","DOI":"10.1016\/j.ejmech.2020.112514"},{"key":"10.1016\/j.bioorg.2023.106593_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112956","article-title":"In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition","volume":"210","author":"Bazin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0065","doi-asserted-by":"crossref","unstructured":"N. McNamara, E. Saunders, S. Varghese, R. Zheng, K. Simpson, D.M. Varma, M. M. Johnson, M. S. Hasan Zahid, E. M. Bachelder, K. M. Ainslie, J. H., No, D. Koh, D. Shum, N. Das, B. Patra, J. Roy, A. Talukdar, D. Ganguly, M. McConville, J. Baell, Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani. Eur. J. Med. Chem. 240 (2022) 114577. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114577.","DOI":"10.1016\/j.ejmech.2022.114577"},{"key":"10.1016\/j.bioorg.2023.106593_b0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2018.05.014","article-title":"Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents","volume":"154","author":"Upadhyay","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0075","article-title":"New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies","volume":"114959","author":"Sabt","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0080","doi-asserted-by":"crossref","unstructured":"I. Barbolla, L.V. Hern\u00e1ndez-Su\u00e1rezQuevedo-Tumailli, D. Nocedo-Mena, S. Arrasate, M. A. Dea-Ayuela, H. Gonz\u00e1lez-D\u00edaz, N. Sotomayor, Lete, E. Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents. Eur. J. Med. Chem. 220 (2021) 113458. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113458.","DOI":"10.1016\/j.ejmech.2021.113458"},{"key":"10.1016\/j.bioorg.2023.106593_b0085","doi-asserted-by":"crossref","unstructured":"J. Lal, K. Ramalingam, R. Meena, S.B. Ansari, D. Saxena, S. Chopra, N. Goyal, D.N. Reddy, Design and Synthesis of Novel Halogen Rich Salicylanilides as Potential Antileishmanial Agents, Eur J Med Chem. 246 (2023) 114996. https:\/\/doi: 10.1016\/j.ejmech.2022.114996.","DOI":"10.1016\/j.ejmech.2022.114996"},{"key":"10.1016\/j.bioorg.2023.106593_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114367","article-title":"Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents","volume":"237","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0095","doi-asserted-by":"crossref","unstructured":"C. Lin, D.D.G. Ja\u00e9n Batista, A.L. Mazzeti, R. Donola Gir\u00e3o, G. M. de Oliveira, I. Karalic, F. Hulpia, M.N.C. Soeiro, L. Maes, G. Caljon, S. Van Calenbergh, N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation. Eur. J. Med. Chem. 231(2022) 114165. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114165.","DOI":"10.1016\/j.ejmech.2022.114165"},{"key":"10.1016\/j.bioorg.2023.106593_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113606","article-title":"Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships","volume":"223","author":"Gupta","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0105","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1021\/acs.jmedchem.9b00412","article-title":"Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)","volume":"62","author":"Reilly","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acsmedchemlett.5b00141","article-title":"Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies","volume":"6","author":"Yempalla","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106593_b0115","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2174\/1381612826666200417154810","article-title":"An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets","volume":"26","author":"Sharma","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2023.106593_b0120","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ejmech.2008.03.039","article-title":"Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation","volume":"44","author":"Poorrajab","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2004.01.009","article-title":"Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents","volume":"39","author":"Mayence","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113516","article-title":"Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents","volume":"221","author":"Mishra","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114878","article-title":"Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity","volume":"244","author":"de Lucio","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0140","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/molecules25081924","article-title":"Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106593_b0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0975-7406.142943","article-title":"Mini review on tricyclic compounds as an inhibitor of trypanothione reductase","volume":"6","author":"Kumar","year":"2014","journal-title":"J. Pharm. Bioallied. Sci."},{"key":"10.1016\/j.bioorg.2023.106593_b0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/117739280700200007","article-title":"Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design","volume":"2","author":"Khan","year":"2007","journal-title":"Drug Target. Insights."},{"key":"10.1016\/j.bioorg.2023.106593_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.jcim.0c00867","article-title":"AIScaffold: A Web-Based Tool for Scaffold Diversification Using Deep Learning","volume":"61","author":"Lai","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2023.106593_b0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2133\/dmpk.19.327","article-title":"In Silico Approaches for Predicting ADME Properties of Drugs","volume":"19","author":"Yamashita","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bioorg.2023.106593_b0165","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106593_b0170","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106593_b0175","doi-asserted-by":"crossref","first-page":"24017","DOI":"10.1039\/D0RA04110F","article-title":"Mild deprotection of the N-tert-butyloxycarbonyl (N-Boc) group using oxalyl chloride","volume":"10","author":"George","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2023.106593_b0180","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1016\/j.tetlet.2013.07.104","article-title":"Efficient copper-catalyzed cross-coupling of 1-Boc-piperazine with aryl iodides and its application in the synthesis of trazodone","volume":"54","author":"Yong","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106593_b0185","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1128\/AAC.49.9.3776-3783.2005","article-title":"Use of Leishmania donovani field isolates expressing the luciferase reporter gene in invitro drug screening","volume":"49","author":"Ashutosh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2023.106593_b0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.bioorg.2023.106593_b0195","doi-asserted-by":"crossref","unstructured":"D.J. Finney, Probit Analysis, third ed., Cambridge University Press, J. Pharm. Sci 60 (1971), 1432. https:\/\/doi.org\/10.1002\/jps.2600600940.","DOI":"10.1002\/jps.2600600940"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:44:22Z","timestamp":1758617062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823002547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"alternative-id":["S0045206823002547"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106593","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106593"}}